N
COGT icon

Nuveen’s Cogent Biosciences COGT Stock Holding History

Nuveen’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32M Sell
831,602
-101,019
-11% -$3.73M 0.01% 873
2025
Q4 		$33.1M Sell
932,621
-6,999
-0.7% -$197K 0.01% 849
2025
Q3 		$13.5M Buy
939,620
+709,508
+308% +$8.41M ﹤0.01% 1382
2025
Q2 		$1.65M Sell
230,112
-3,740
-2% -$20.7K ﹤0.01% 2387
2025
Q1 		$1.4M Sell
233,852
-79,247
-25% -$621K ﹤0.01% 2484
2024
Q4 		$2.44M Sell
313,099
-1,896
-0.6% -$18.9K ﹤0.01% 2291
2024
Q3 		$3.4M Sell
314,995
-449,352
-59% -$4.38M ﹤0.01% 2171
2024
Q2 		$6.44M Sell
764,347
-257,744
-25% -$1.95M ﹤0.01% 1820
2024
Q1 		$6.87M Buy
1,022,091
+777,343
+318% +$4.81M ﹤0.01% 1813
2023
Q4 		$1.44M Buy
244,748
+23,371
+11% +$179K ﹤0.01% 2569
2023
Q3 		$2.16M Sell
221,377
-32,551
-13% -$386K ﹤0.01% 2270
2023
Q2 		$3.01M Buy
253,928
+14,842
+6% +$170K ﹤0.01% 2163
2023
Q1 		$2.58M Buy
239,086
+20,902
+10% +$267K ﹤0.01% 2236
2022
Q4 		$1.08M Sell
218,184
-460,863
-68% -$5.71M ﹤0.01% 2653
2022
Q3 		$3.37M Buy
679,047
+480,816
+243% +$6.59M ﹤0.01% 2122
2022
Q2 		$983K Buy
198,231
+83,583
+73% +$570K ﹤0.01% 2785
2022
Q1 		$780K Sell
114,648
-1,959
-2% -$13.6K ﹤0.01% 2892
2021
Q4 		$926K Sell
116,607
-9,458
-8% -$82.2K ﹤0.01% 2886
2021
Q3 		$1.13M Sell
126,065
-3,785
-3% -$29K ﹤0.01% 2947
2021
Q2 		$1.05M Buy
+129,850
New +$1.1M ﹤0.01% 2986

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Nuveen's COGT Position: Q1 2026 in Review

Nuveen reduced its Cogent Biosciences (COGT) stake by 11% in Q1 2026, selling an estimated $3.73M and leaving 831,602 shares worth $32M. The position accounts for 0.01% of the portfolio, ranked #873.

Nuveen first reported a position in COGT in Q2 2021 and has held it in 20 quarters since. The position peaked at $33.1M in Q4 2025. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Nuveen held 831,602 shares of Cogent Biosciences worth $32M as of Q1 2026.
  • Nuveen sold 101,019 Cogent Biosciences shares in Q1 2026, an estimated $3.73M.
  • Cogent Biosciences made up 0.01% of Nuveen's portfolio in Q1 2026, its #873 holding.
  • Nuveen first reported a position in Cogent Biosciences in Q2 2021 and has held it in 20 quarters since.
  • Nuveen's Cogent Biosciences position peaked at $33.1M in Q4 2025.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.